Investor Type | Firm |
Industries | IT (& TMT) • BioTech • Businesses Solutions • Hardware (& Manufacturing) • CleanTech • HealthTech (& Fitness) • Material Science • Medical Devices (& Hospital Services) • Healthcare (& Wellness) • Nanotechnology • Pharmaceutical (& Medicine) |
Stages | Seed, Series A, Series B |
Investing | United Kingdom • Germany |
Investment Range | $100,000 - $5,000,000 |
Investment Sweet Spot | $1,500,000 |
Assets Under Management | $24,000,000 |
Bayern Kapital is a venture capital firm based in Landshut, Germany with a focus on fostering innovation and entrepreneurship within the technology sector in the region. They have been a strong investment partner for nearly three decades, channeling funds towards the development of high-tech companies. With assets under management of over 240 million euros and having made more than 320 investments, their experience in venture capital is extensive. Bayern Kapital specializes in a wide range of industries, including but not limited to biotechnology, life sciences, information technology, software, medical technology, materials science, nanotechnology, and environmental technology. They support businesses in various stages of development, from seed to scale-up, with investment amounts ranging from 100,000 euros to 5 million euros, with a sweet spot of around 1.5 million euros. Their capabilities in funding are robust, offering up to 25 million euros for growth and international expansion of tech companies. Bayern Kapital is particularly interested in visionary founding teams capable of revolutionizing whole sectors and contributing positively to society. As one of the most active and well-capitalized venture capital investors in the German-speaking region, they are committed to supporting tech companies, particularly in Bavaria, from the seed phase through to more capital-intensive phases of expansion. Bayern Kapital emphasizes their passion and outstanding network, which they leverage to benefit their portfolio companies. Their engagement is not only financially inclined as they seek to foster conditions where innovative solutions can thrive and assist companies in connecting with national and international investors.